Back

Mechanisms of atrial-fibrillation-induced ventricular dysfunction and recovery in the human left ventricular myocardium

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atrial and ventricular remodelling in atrial fibrillation Mechanisms for Heart Failure and Cardiac Complications ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Laura Stengel

Regensburg (Germany)

6 More presentations in this session

Presentation thumbnail
Left atrial strain parameters are able to predict presence of atrial fibrillation
Associate Professor J. Plasek (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
Integrating single-cell sequencing and genetic lineage tracing reveals endothelial plasticity during atrial remodeling
Doctor Z. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The connection site of the Bachmann bundle to the left atrium affects atrial electrical and anatomical remodeling
Doctor S. Terao (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Impact of adjacent thoracic structures in negative left atrial remodelling in atrial fibrillation
Doctor R. Varini (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Elevation of circulating FGF23 in chronic kidney disease promotes atrial fibrosis through the AKT pathway
Professor T. Liu (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial and ventricular remodelling in atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Newly diagnosed heart failure in patients with atrial fibrillation referred for catheter ablation - identifying patients with arrhythmia-induced cardiomyopathy
thumbnail
Congress Presentation
Atrial fibrillation is perpetuated by human heart secretome in ex-vivo langendorff-perfused hearts.
thumbnail
Congress Presentation
Novel translational porcine large animal model for Arrhythmia-Induced Cardiomyopathy (AICM): bridging pathomechanisms to therapeutic innovations

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources